Justice is a comforting word, but in the wake of Jasveen Sangha’s fifteen-year sentence, it is also a lie. The media is currently feasting on the carcass of a "Ketamine Queen," painting a picture of a singular villain who swooped in to destroy a beloved icon. It is a clean, cinematic narrative. It’s also a complete distraction.
By focusing on the street-level dealer, the legal system and the public are ignoring the massive institutional failure that made her existence inevitable. We are patting ourselves on the back for locking up a supplier while the actual architecture of celebrity medical abuse remains untouched. If you think this sentence fixes the problem, you haven’t been paying attention to how the elite actually die.
The Myth of the Predatory Outsider
The prevailing narrative suggests that Sangha "targeted" Matthew Perry. This ignores the brutal reality of high-functioning addiction: the user is often the most sophisticated architect of their own supply chain. Perry wasn’t a naive victim of a street pusher; he was a man with unlimited resources operating within a medical gray zone that we refuse to regulate.
When a celebrity dies from a "hot" batch or an overdose, the public demands a head on a spike. Sangha provides that head. But she didn't invent the demand. She filled a vacuum created by a medical industry that treats addiction as a PR problem rather than a chronic neurological condition.
I have watched this play out in Hollywood for decades. When a high-net-worth individual wants a substance, they don't start in a dark alley. They start in a white-walled clinic. They start with a licensed professional who is more afraid of losing a lucrative client than they are of violating a standard of care. Sangha was just the last link in a chain that began with a prescription pad.
The Professional Enabler Pipeline
The true scandal isn't the woman in the North Hollywood stash house. It’s the licensed doctors—Salvador Plasencia and Mark Chavez—who turned their medical degrees into high-priced vending machines.
The competitor articles love to focus on the "Ketamine Queen" moniker because it sounds like a Batman villain. It sells ads. But the nuance we are missing is that the medical system itself provided the blueprints for his demise.
- Step 1: A legitimate medical treatment (Ketamine infusion therapy) is established.
- Step 2: A patient with a history of profound substance abuse is cleared for that treatment without oversight.
- Step 3: When the legal clinic stops or limits the dose, the patient uses their medical knowledge of the drug to seek "off-book" sources.
- Step 4: Dishonest doctors bridge the gap between the pharmacy and the street.
The "K-Queen" didn't need to market herself. The medical professionals did the marketing for her by normalizing the drug and then failing to manage the patient's dependency.
We Are Asking the Wrong Questions
Most people are asking, "How could she do this?" or "Is 15 years enough?"
These are low-resolution questions. The question you should be asking is: Why is the legal threshold for medical negligence so high that it takes a literal corpse before we look at the distribution of controlled substances to the elite?
We treat celebrities like gods until they die, then we treat them like children who were tricked by the big bad wolf. This infantilization of Perry does him a disservice. He was an expert on his own addiction. He wrote about it. He lived it. To suggest he was merely a victim of a dealer is to ignore the massive, systemic failure of the recovery industry that took millions of his dollars and failed to provide a safety net that could withstand the weight of his fame.
The Ketamine Gold Rush
We are currently in a Wild West of psychedelic and dissociative medicine. Ketamine is being hailed as a miracle for depression. In many cases, it is. But the rush to monetize these treatments has outpaced the creation of safeguards.
The "nuance" the media ignores is that Ketamine isn't just another street drug; it’s a pharmaceutical grade product that was diverted. This isn't a story about "drugs" in the abstract. It's a story about supply chain integrity.
If Sangha was able to move the volume she moved, it means the tracking systems for pharmaceutical ketamine are laughably porous. We can track a package of socks from a warehouse in Ohio to a doorstep in Maine with 99.9% accuracy, yet we somehow "lose" thousands of vials of a controlled anesthetic?
The Cost of the "Clean" Narrative
Locking up Sangha is a tactical win but a strategic disaster. It allows the public to feel a sense of closure. It lets the DEA put a notch in their belt. It lets the "Friends" fans feel like some debt has been paid.
But meanwhile:
- The "Dr. Feelgoods" are still practicing under different names.
- The "concierge" medical services still prioritize client satisfaction over patient safety.
- The loop between legitimate therapy and illicit addiction remains wide open.
If you want to actually prevent the next Matthew Perry death, you don't do it by adding five years to a dealer's sentence. You do it by mandating real-time, federalized tracking of every single vial of anesthetic produced in this country. You do it by making it a felony for a doctor to treat an addict with dissociative drugs without a third-party sobriety monitor present.
But we won't do that. It's too expensive. It's too much paperwork. It's much easier to find a woman with a flashy nickname, throw the book at her, and call it a day.
The Illusion of Progress
Let’s look at the numbers. The United States spends billions on the drug war. In that time, overdose deaths have not plummeted; they have shifted. We move from heroin to oxy to fentanyl to diverted ketamine.
The Sangha trial wasn't about public safety. It was about optics. When a famous person dies, the government has to prove it still has teeth. They find the most "distasteful" person involved—the one who looks the part of a dealer—and they make an example of them. If Perry had been a homeless man in MacArthur Park who bought from Sangha, she wouldn't even be in a courtroom today.
The 15-year sentence is a tax on the dealer for being involved in a "high-profile" tragedy. It is not a deterrent. The profit margins are too high, and the demand is too desperate. For every "Ketamine Queen" you take off the board, three "Ketamine Princes" are already looking at her old client list.
Stop Looking at the Dealer, Start Looking at the Mirror
We, as a culture, demand that our stars be perfect, then we demand they be vulnerable, then we are shocked when they use their vast wealth to numb the pain of that cycle. We created the market that Sangha served.
Her sentence is a band-aid on a gunshot wound. It’s a way for us to avoid talking about the fact that our medical system is tiered: one for the poor (who get prison) and one for the rich (who get "concierge" access to the very things that kill them).
The "status quo" wants you to think the bad guy is in jail and the world is safer. The truth is that the system that killed Matthew Perry is still running at 100% capacity. It's just looking for its next "client."
Go ahead. Celebrate the sentence. Just don't act surprised when it happens again next month.
The dealer is in a cell. The doctors are in plea deals. The fans have their closure. And the pharmaceutical pipeline is already priming the next vial.
This isn't justice. It’s an intermission.
